Works matching IS 15430790 AND DT 2023 AND VI 21 AND IP 12
Results: 8
Addressing Unmet Need in the Management of Patients With ER+/HER2–, ESR1-Mutated Metastatic Breast Cancer: Clinician’s Perspective.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 623
- By:
- Publication type:
- Article
Chemotherapy and Immunotherapy in Early-Stage NSCLC: Neoadjuvant vs Adjuvant Therapy.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 648
- Publication type:
- Article
Update on the CAPTIVATE Trial of Ibrutinib Plus Venetoclax.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 654
- Publication type:
- Article
Breakthroughs in Cancer Care.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 618
- By:
- Publication type:
- Article
The National Cancer Institute’s Clinical Trials Innovation Unit.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 663
- Publication type:
- Article
Novel Combination Approaches to Locoregional and Systemic Therapy in the Management of Primary and Metastatic Liver Tumors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 633
- By:
- Publication type:
- Article
EGFR Inhibitor Rechallenge in Metastatic Colorectal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 670
- Publication type:
- Article
Preventing Infectious Complications in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2023, v. 21, n. 12, p. 676
- Publication type:
- Article